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Abstract
Animal embryonic stem cells (ESCs) provide powerful tool for studies of early embryonic development, gene targeting,
cloning, and regenerative medicine. However, the majority of attempts to establish ESC lines from large animals, especially
ungulate mammals have failed. Recently, another type of pluripotent stem cells, known as induced pluripotent stem cells
(iPSCs), have been successfully generated from mouse, human, monkey, rat and pig. In this study we show sheep fibroblasts
can be reprogrammed to pluripotency by defined factors using a drug-inducible system. Sheep iPSCs derived in this fashion
have a normal karyotype, exhibit morphological features similar to those of human ESCs and express AP, Oct4, Sox2, Nanog
and the cell surface marker SSEA-4. Pluripotency of these cells was further confirmed by embryoid body (EB) and teratoma
formation assays which generated derivatives of all three germ layers. Our results also show that the substitution of
knockout serum replacement (KSR) with fetal bovine serum in culture improves the reprogramming efficiency of sheep
iPSCs. Generation of sheep iPSCs places sheep on the front lines of large animal preclinical trials and experiments involving
modification of animal genomes.
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Introduction
ESC lines, derived from the inner cell mass (ICM) of a blastocyst,
can divide indefinitely and are capable of creating all cell types of an
adult animal [1]. Isolation of ESC lines from domesticated large
animals and ungulate mammals has the potential to enable the
precise genetic engineering of livestock for improved production
traits,disease resistance andbiopharming. Because oftheir potential
use for targeted gene manipulation, isolation of ESCs in livestock
may overcome current limitations upon efficient gene transfer by
providing an abundance of pluripotent stem cells to be genetically
manipulated through the use of conventional recombinant DNA
techniques. Unfortunately, genetic alteration in domestic animals
has proven to be extremely difficult outside of murine models [2,3].
The capability to establish pluripotent stem cell lines from large
animals is therefore crucial to applications of gene targeting
technologies in domestic livestock and non-rodent models.
Domestic sheep are one of the earliest animals to have been
domesticated for agricultural purposes. The establishment of sheep
ESCs would useful in a number of applications, such as the
production of genetically targeted sheep with desired traits and the
improvementofsomaticcellnucleartransferefficiencybygeneration
of pluripotent stem cells [4,5]. More importantly, sheep ESC
technology offers an excellent large animal model for human stem
cell research because sheep share more phylogenetic characteristics
with humans than rodents [6]. Several articles have reported the
derivation of ESC-like cells from the ICM of sheep blastocysts [6,7].
However, the cells derived in these studies do not meet the full
criteria to qualify as stable and pluripotent ESCs because they are
unable to be maintained in an undifferentiated state beyond two
passages in culture. Recently, mouse and human somatic cells have
been reprogrammed in vitro to induced pluripotent stem cells (iPSCs)
by ectopic expression of defined transcription factors. These iPSCs
are similar to ESCs in terms of gene expression, pluripotency and
epigenetic status, and hold great potential for use in regenerative
medicine and in vitro disease modeling [8–16]. More recently, iPSCs
have also been successfully generated from other animals such as
monkeys [17], rats [18] and pigs [19–21]. In this paper, we report
the first generation of iPSCs from sheep somatic cells using a drug-
inducible expression system of murine-derived pluripotency factors.
Materials and Methods
Cell culture
Sheep fibroblasts used in this report were obtained from a
Mongolian sheep fetus at day 40 of gestation. The isolation of
sheep fetal fibroblasts (SFFs) was done as previously described
[22]. Briefly, an explanted sheep fetus was dissociated manually
and then treated with 0.25% trypsin-EDTA (HyClone, Logan,
UT, USA). Primary cultures were grown on tissue culture plates
coated with 0.1% gelatin (Sigma, St Louis, MO, USA) until the
first passage, after which standard tissue culture plates were used.
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(DMEM, HyClone) supplemented with 10% fetal bovine serum
(FBS, Invitrogen, Carlsbad, CA, USA). SFFs were passaged upon
reaching 95% confluence with 0.25% trypsin-EDTA and infected
with reprogramming virus between passages 3 and 5. 293T cells
(ATCC, Manassas, VA, USA) were maintained in the same
medium. Sheep iPSCs were maintained in ESC medium com-
posed of Knock-out DMEM (Gibco-BRL, Grand Island, NY)
supplemented with 20% Serum Replacement (SR, Gibco) or FBS,
0.1 mM b-mercaptoethanol (Gibco), 1% nonessential amino acids
(Hyclone), 2 mM glutamine (Hyclone), and 4 ng/ml hFGF2
(Peprotech, London, UK). Sheep iPSCs were passaged by enzyma-
tic dissociation using 1 mg/ml collagenase IV(Gibco)and main-
tained on feeder layers of mouse embryonic fibroblasts (MEF) that
were mitotically inactivated by mitomycin C (Sigma). Permission
to handle all animal samples was granted by Peking University
Health Science Center Ethical Committee (PKU20103088).
Lentivirus production and infection
293T cells were plated at 6610
6 cells per 100 mm dish and
incubated overnight. The generation and structure of doxycycline-
controlled Tet-on-inducible lentiviruses expressing mouse-derived
Oct4, Sox2, c-Myc and Klf4 has been described in previous reports
[23,24]. The c-DNA for GFP was cloned into the EcoRI sites of the
same vector backbone (FUW-tetO). Expression of reverse tetracy-
cline transactivator (rtTA) was driven by a constitutively active
human ubiquitin C promoter alpha promoter in the FUW lentiviral
backbone (FUW-M2rtTA). To produce lentiviral particles used to
stably reprogram fibroblasts into iPSCs, 293T cells were transfected
with a mixture of viral plasmid and packaging constructs expressing
the viral packaging functions and the VSV-G protein with
Lipofectamine 2000 (Invitrogen). Viral supernatant was harvested
at 24 and 48 hours after transfection. A total of 30 ml of
supernatant was typically harvested per virus. Viral supernatant
was filtered through a 0.45 mm syringe filter (Millipore, Billerica,
MA, USA), and loaded into a AmcionHUltra-15 Centrifugal Filter
(Millipore) for concentration. Viral supernatant was concentrated
approximately100-foldbycentrifugationat6000 rpm for20 minat
4uC. Viral concentrates were stored at 280uC. Infections were
carried out on 35 mm tissue culture plates in 1 ml of medium
containing 5 mg/ml polybrene (Sigma) with 5–10 ml of each viral
concentrate. SFFs were infected at a density of 5610
4 cells/plate,
and the medium was replaced 24 hrs after infection. Infection was
repeated two times. Cells were subsequently dissociated by trypsin
Figure 1. Doxycycline (Dox) controlled Tet-on-inducible lentiviral system for induction of pluripotency in sheep fetal fibroblasts
(SFFs). (A) Expression of GFP in SFFs is not observed when Dox is absent from the culture medium. Addition of Dox (2 mg/ml) to the culture medium
induces expression of GFP 48 hour after treatment. (B) The time schedule for sheep iPSCs induction. Scale bars: =50 mm.
doi:10.1371/journal.pone.0015947.g001
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reprogramming, culture medium was replaced by ESC medium
supplemented with 2 mg/ml doxycycline (Dox).
RNA isolation and reverse transcription
Total RNA was purified with an RNeasy Mini Kit (Qiagen,
Valencia, CA, USA) as per the manufacturer’s instructions.
Approximately 1 mg of total RNA from each sample was used
for Oligo(dT)20 – primed reverse transcription (SuperScript TM
III First-Strand Synthesis System for RT-PCR, Invitrogen). PCR
products were resolved on (1.5%) agarose gels and visualized by
ethidium bromide staining. Images were taken using a gel imaging
system (Bio-Rad). The primer sequences employed are displayed
in Supplementary Table S1.
Alkaline phosphatase staining and
immunocytochemistry
Alkaline phosphatase (AP) staining was performed using the
Alkaline phosphatase kit (Roche Applied Science, Mannheim,
Germany) according to the manufacturer’s instructions. For
immunocytochemistry, cells were fixed with 4% paraformaldehyde
for 10 min at room temperature. After washing with PBS, cells were
treated with PBS containing 10% normal bovine serum albumin
(Sigma) and 0.1% Triton X-100 for 30 min at room temperature,
then incubated with primary antibodies at 4uC overnight. Primary
antibodies included SSEA-1 (1:100, Santa Cruz Biotechnology,
SantaCruz,CA,USA),SSEA-3(1:100,SantaCruz),SSEA-4(1:100,
Chemicon,Temecula,CA,USA),Tra-1-60(1:100,Chemicon),Tra-
1-81 (1:100, Chemicon), Nanog (1:100, Abcam, Cambridge, UK),
Oct4 (1:100, Santa Cruz), Sox2 (1:100, Chemicon), b III-Tubulin
(1:100, Chemicon), Desmin (1:100, Santa Cruz), Cytokeratin (1:100,
Santa Cruz). Normal mouse or rabbit serum was used as a negative
control. Localization of antigens was visualized with anti-rabbit or
anti-mouse IgG secondary antibodies conjugated with fluorescein
(Santa Cruz). Nuclei were counterstained with DAPI.
In vitro differentiation
Spontaneous differentiation of sheep iPSCs through EB
formation was carried out as previously described [10,11]. Briefly,
sheep iPSCs were cultured in ESC media without hFGF2, hLIF
and Dox in non-tissue-culture-treated plates. After 8 days in
suspension culture, EBs were transferred to gelatin-coated plates
and cultured in differentiation medium for another 8 days.
Teratoma formation
Sheep iPSCs were harvested by collagenase IV treatment,
suspended in PBS and delivered via subcutaneous injection into
the dorsal flanks of severe combined immunodeficient (SCID)
mice. Eight weeks after injection, tumors were explanted, fixed in
4% paraformaldehyde, embedded in paraffin, and examined
histologically using hematoxylin and eosin staining.
Karyotyping
Sheep iPSCs were prepared for karyotype analysis by
incubation in medium containing 0.1 mg/ml colcemid for
5 hours. Cells were trypsinized, resuspended in 0.075 M KCl,
Figure 2. Morphological changes of SFFs undergoing reprogramming to iPSCs. (A) SFFs prior to induction of reprogramming (B) Image of
reprogrammed sheep iPSC colony colony day 14, (C) day 16, (D) day 18, (E) day 20, (F) day 25, and (G) day 30 post-transduction. (H) Image of day 30
colony post-transduction with high magnification. (I) Positive AP staining of a colony with typical human ESC morphology. Scale bars: =50 mm.
doi:10.1371/journal.pone.0015947.g002
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acid at room temperature for 5 min. Centrifugation and fixing
steps were repeated three times. Harvested cells were stained using
a standard G-banding technique.
Results
Optimization of drug-inducible lentiviral transduction for
SFFs
Because induction of iPSCs requires use of lentivirus with high
transduction efficiencies, a drug-inducible GFP-expressing lentivi-
rus was added in all transduction experiments to monitor infection
efficiency. Over 70% of the SFFs transduced were found to
express GFP at high levels 48 hr after Dox addition (Figure 1A).
Generation of sheep iPSCs
A time table for sheep iPSC induction is shown in Figure 1B.
SFFs were transduced at a density of 5610
4 cells per 35 mm plate
using lentiviruses containing mouse Oct4, Sox2, c-Myc, Klf4, and
rtTA genes. Three days after transduction, the cells were
trypsinized and plated onto mitomycin C treated feeder cells
and cultured using ESC medium supplemented with 2 mg/ml Dox
(Figure 2A). Approximately fourteen days later, a few colony-like
cell aggregates composed of 5–10 cells each became visible under
bright field microscopy (Figure 2B). Over the next week, the size of
colonies gradually increased (Figure 2C–E). About day 25 post-
transduction, these colonies began to exhibit some human ESC-
like features. Colonies became more compact and flatter
(Figure 2F). By day 30, ES-cell like colonies had grown very
large, and cells within the colonies exhibited morphology similar to
that of human ES cells, with a high nucleus-to-cytoplasm ratio and
prominent nucleoli (Figure 2G, H). ESC-like colonies were picked
and mechanically dissociated into small clumps on top of new
feeder layers. AP staining was subsequently used to classify ESC-
like colonies as undifferentiated or differentiated. Large ESC-like
colonies exhibiting morphology similar to that of human ES cells
were found to stain positive for AP (Figure 2I). Cell cultures
untreated with Dox were not observed to give rise to any ESC-like
colonies (Figure 3A). To test for optimal conditions of sheep iPSC
induction and culture, ESC medium containing FBS and KSR
were both tested for capacity to maintain cells in an undifferen-
tiated state. We found that the number of AP positive colonies
generated from medium supplemented with FBS was significantly
greater than in cultures supplemented with KSR (Figure 3B).
Expression of pluripotent markers in sheep iPSCs
To confirm that colonies exhibiting ESC-like morphology
expressed proteins associated with pluripotent cells, sheep iPSC
Figure 3. Brightfield microscopy of colonies staining positive for AP following addition of Dox to culture media. Infected SFFs were
split into separate dishes and cultured in the presence or absence of Dox. (A) Representative images of Dox negative and Dox positive dishes stained
for AP at day 25. (B) Infected SFFs were split into separate dishes and cultured in ESC medium supplemented with Dox and FBS or KSR respectively.
Cell cultures were stained for AP day 25 following the initial addition of Dox.
doi:10.1371/journal.pone.0015947.g003
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markers associated with undifferentiation in human and mouse
cells. Immunofluorescence staining showed that colonies were
positive for Oct4, Sox2, Nanog, and SSEA-4, whereas the same
colonies were negative for SSEA-1, SSEA-3, Tra-1-60, and Tra-1-
81 (Figure 4). Human or mouse ESCs were used as positive
controls for immunostaining (Supplementary Figure S1). RT-PCR
demonstrated that murine Oct4, Sox2, Klf4 and c-Myc continued
to be expressed in sheep iPSC clones through Passage 20, and that
endogenous expression of sheep Sox2 and Nanog were activated
as well (Figure 5A). Sheep iPSCs could be well maintained beyond
20 passages in ESC medium supplemented with Dox. Following
withdrawal of Dox at passage 20, expression of all four transgenes
was quickly downregulated, and close to 90% of colonies turned
AP negative (Figure 5B).
In vitro differentiation of sheep iPSCs
To assess pluripotency of sheep iPSCs in vitro, we generated
EBs from the iPSCs using suspension culture. Sheep iPSCs were
observed to form EBs in suspension after 8 days (Figure 6A). EBs
were transferred to gelatin-coated plates and cultured for an
additional 8 days. Immunofluorescence staining showed that the
detected cells were positive for b III-Tubulin (ectoderm), Desmin
(mesoderm), and Cytokeratin (endoderm) (Figure 6B-D).
Teratoma formation and karyotype analysis from sheep
iPS cells
To test for in vivo pluripotency, sheep iPSCs were transplanted at
passage 10 into the subcutaneous flanks of SCID mice. Eight
weeks after injection, palpable tumors were observed. Histological
examination revealed the presence of derivatives of all three germ
layers within the tumor including glandular epithelium, muscle
and neural epithelium (Figure 6E-G). Karyotyping was also
conducted on iPSCs at passage 15, and revealed a normal
karyotype of 54XX (Figure 6H).
Discussion
Derivation of stable ESC lines has been reported for the mouse
[1,25], hamster [26], rhesus monkey [27], rat [28,29], and human
[30], but validated ESC lines have yet to be established in farm
animal species. There are several reasons for the reported
difficulties in deriving ESCs from large animals including difficulty
in isolating cells at the appropriate stage of embryonic develop-
ment, suboptimal culture conditions and improper cell passaging
methods. Although production of sheep ESC-like cells from early
embryos has been reported, these sheep ESC-like cells have not
been able to be maintained beyond two passages [6,7]. Induction
of pluripotency in somatic cells by defined factors has been
Figure 4. Immunofluorescence staining demonstrates that sheep iPSC colonies are positive for expression of Oct4, Sox2, and
Nanog, as well as the surface marker SSEA-4. Colonies were not observed to express SSEA-1, SSEA-3, Tra-1-60, or Tra-1-81. Scale bars: =50 mm.
doi:10.1371/journal.pone.0015947.g004
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iPSC technology offers hope for a practical method by which
pluripotent stem cells may be generated from other domestic
animals. Here, we generated pluripotent stem cells using drug-
inducible expression of defined factors in sheep fetal fibroblasts.
The Doxycycline (Dox) controlled tet-on-inducible system has
successfully been applied to generate iPSCs from mouse, human
and pig somatic cells [19,23,32]. Use of this system is a predictable
and highly reproducible platform for iPSC generation and should
facilitate the study of early molecular events leading to epigenetic
reprogramming of somatic cells [32]. In the present study, we used
the Dox controlled tet-on-inducible system to generate and
maintain stable sheep ESC-like colonies from fetal fibroblasts. As
addition of Dox to culture media was necessary for the induction
and maintenance of sheep ESC-like colonies, it is likely that the
culture conditions used in this paper are not sufficient to maintain
pluripotency in sheep iPSCs alone. Withdrawal of Dox in cultures
of stably reprogrammed iPSCs resulted in the silencing of
exogenous genes, and differentiation of cells as evidenced by a
switch from positive to negative AP staining. To culture sheep
iPSCs without use of a drug inducible system, certain growth
factors or chemical inhibitors may be required to prevent
differentiation. The challenge of optimizing culture conditions
for maintenance of pluripotency is the primary reason stable ESC
lines have yet to be established in large animals [33,34]. Cytokines
and growth factors that inhibit spontaneous differentiation in
mouse and primate ES cell lines such as LIF and bFGF do not
inhibit differentiation of pluripotent cells for many large animal
ICM and epiblast primary cultures [33–36]. In this study, sheep
iPSCs were not able to be maintained in an undifferentiated state
following withdrawal of Dox even when hLIF and hFGF was
added to the medium. Although cells were characterized by a
cobble stone patterning with large nucleoli, sheep iPSC colonies
generated from the drug-inducible system did not possess a
defined, highly refractive edge characteristic of human or mouse
ESC and iPSCs. The differences in cell morphology between
sheep iPSCs and pluripotent stem cells derived from other animals
may be due to imperfect culturing conditions. The maintenance of
sheep iPSCs under this drug-inducible system provides a useful
platform for studying the role of different cytokines and growth
factors in sheep iPSCs self-renewal. This in turn should facilitate
the optimization of culture conditions for iPSCs maintenance, and
eventual establishment of true ESCs from sheep blastocysts.
While FBS has been used for the establishment of mouse ESC
and iPSC lines in a majority of laboratories [11,25], knockout
serum replacement (KSR), which is a defined, serum-free
Figure 5. Maintenance of sheep ESC-like colonies is dependent on addition of Dox to culture medium. (A) Three representative sheep
iPSC clones (siPS1, siPS2 and siPS3) were selected for analysis of exogenous and endogenous gene expression. (B) Expression of exogenous
pluripotency transgenes declined to undetectable levels 15 days after withdrawal of Dox (left panel). The majority of iPSC colonies were observed to
turn AP negative following withdrawal of Dox.(right panel).
doi:10.1371/journal.pone.0015947.g005
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and primate ESCs and iPSCs in culture [10,30]. Although detailed
information concerning its composition is restricted, KSR does not
contain any undefined growth factors or factors that promote
differentiation [37]. Our results showed that the replacement of
KSR with FBS in culture medium improved the reprogramming
efficiency and integrity of sheep iPSCs. These results suggest that
serum substrates in FBS may play a vital role in generation of
sheep iPSCs, and that these putative factors are not included in
KSR.
Cell surface markers provide a powerful tool for characteriza-
tion and isolation of pluripotent stem cells. Therefore, identifica-
tion of surface markers expressed on iPSCs is important for
pluripotent stem cells. SSEAs including SSEA-1 SSEA-3 SSEA-4,
have widely used as cell surface marker to monitor pluripotency of
ESCs. Dattena et al. reported that sheep ESCs express SSEA-1,
SSEA-3, and SSEA-4 [6]. In this study, sheep iPSCs showed
expression of SSEA-4, but not SSEA-1 and SSEA-3. Moreover,
our results indicate that sheep iPSCs also lack Tra-1-60 and Tra-1-
81, which are characteristic of human ESCs and iPSCs [10,30].
Figure 6. Sheep iPSCs differentiate into derivatives of all three germ layers in vitro and in vivo. (A) Sheep iPSCs form embryoid bodies in
suspension culture following withdrawal of hFGF, hLIF and Dox from culture media. Immunofluorescence staining shows differentiation of sheep
iPSCs give rise to cells expressing markers of the three germ layers: (B) b III-Tubulin, (C) Desmin, and (D) Cytokeratin. Hematoxylin and eosin staining
of teratomas derived from sheep iPSCs reveals the presence of tissues from all three germ layers: (E) glandular epithelium (endoderm), (F) muscle
(mesoderm), and (G) neural epithelium (ectoderm). (H) Sheep iPSCs at passage 15 showed a normal karyotype of 54XX. Scale bars: =50 mm.
doi:10.1371/journal.pone.0015947.g006
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expression and epigenetic status of pluripotent cell-specific genes
between sheep ESCs, iPSCs and somatic cells targeted for
reprogramming such as fibroblasts to understand the molecular
processes behind induction of pluripotency in sheep cells.
Unfortunately, these assays will be difficult to conduct in a sheep
model without the release of more comprehensive sheep genomes
and commercial sheep gene-chips.
An important proof for the establishment of ungulate plurip-
otent stem cell lines is demonstration of pluripotency either by
differentiation into defined cell types in vitro or by teratoma
formation in vivo. These proofs have been common practice with
both mouse and primate ESC and iPSC lines [1,10,11,30]. In the
present study, pluripotency of sheep iPSCs was demonstrated by
derivation of cells of all three germ layers in EB and teratoma
formation assays. However, future work such as chimera
formation though injection of sheep iPSCs into developing
blastocysts must be performed to truly confirm that these cells
are ESC-like.
Supporting Information
Table S1 Primer sets for PCR reactions.
(DOC)
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